Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cytogam in Abdominal Organ Transplant Recipients at High Risk for CMV
NCT01509404Phase 4Completed
- Sponsor
- Medical University of South Carolina
- Start
- Nov 2011
- Primary completion
- Dec 2014
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of IgPro10 in cytomegalovirus disease (CMV), sponsored by Medical University of South Carolina. Primary endpoint: Number of Patients With Late CMV Disease at 2 years. Started Nov 2011; status: completed.
02
Drugs
IgPro10
03
Conditions
cytomegalovirus disease (CMV)
Beyond the preview
Go deeper on NCT01509404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01509404.